Cardio-Oncology: Fluoropyrimidine Chemotherapy Treatment with 5-fluorouracil (5FU) or capecitabine

Clinical Trial Finder

This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Cardio-pulmonary and Analgesic Effects of Pre-peritoneal VS Epidural Infusion of L-bupivacaine on Abd. Cancer Patients

Condition:   Abdominal Cancer
Interventions:   Procedure: levo-bupivacaine infusion via Thoracic epidural catheter;   Procedure: levo-bupivacaine infusion via preperitoneal catheter
Sponsor:   South Egypt Cancer Institute
Active, not recruiting

Self-Management Program and Survivorship Care Plan in Improving the Health of Cancer Survivors After Stem Cell Transplant

Conditions:   Cancer Survivor;   Allogeneic Hematopoietic Stem Cell Transplantation Recipient;   Autologous Hematopoietic Stem Cell Transplantation Recipient
Interventions:   Other: Best Practice;   Other: Internet-Based Intervention;   Other: Survey Administration
Sponsors:   Fred Hutchinson Cancer Research Center;   National Cancer Institute (NCI)
Not yet recruiting

A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

Condition:   Small Cell Lung Carcinoma
Interventions:   Drug: Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody;   Drug: Carboplatin;   Drug: Etoposide;   Drug: Placebo
Sponsor:   Hoffmann-La Roche
Active, not recruiting

A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)

Condition:   Non-Small-Cell Lung
Interventions:   Drug: Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody;   Drug: Placebo Comparator;   Drug: Nab-paclitaxel;   Drug: Pemetrexed;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Gemcitabine
Sponsor:   Hoffmann-La Roche
Recruiting

A Study in Participants Previously Enrolled in a Genentech− and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)

Condition:   Cancer
Intervention:   Drug: Atezolizumab
Sponsor:   Hoffmann-La Roche
Recruiting